CY1123418T1 - Παραγωγα αζιθρομυκινης με ιδιοτητες ενισχυσης επιθηλιακου φραγμου - Google Patents

Παραγωγα αζιθρομυκινης με ιδιοτητες ενισχυσης επιθηλιακου φραγμου

Info

Publication number
CY1123418T1
CY1123418T1 CY20201100750T CY201100750T CY1123418T1 CY 1123418 T1 CY1123418 T1 CY 1123418T1 CY 20201100750 T CY20201100750 T CY 20201100750T CY 201100750 T CY201100750 T CY 201100750T CY 1123418 T1 CY1123418 T1 CY 1123418T1
Authority
CY
Cyprus
Prior art keywords
epithelial barrier
azithromycin
derivatives
enhancement properties
barrier enhancement
Prior art date
Application number
CY20201100750T
Other languages
Greek (el)
English (en)
Inventor
Fridrik Runar GARDARSSON
Fredrik Lehmann
Peter Teodorovic
Original Assignee
Epiendo Pharmaceuticals Ehf.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=55133040&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1123418(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Epiendo Pharmaceuticals Ehf. filed Critical Epiendo Pharmaceuticals Ehf.
Publication of CY1123418T1 publication Critical patent/CY1123418T1/el

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Materials For Medical Uses (AREA)
CY20201100750T 2015-11-19 2020-08-12 Παραγωγα αζιθρομυκινης με ιδιοτητες ενισχυσης επιθηλιακου φραγμου CY1123418T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1520419.1A GB201520419D0 (en) 2015-11-19 2015-11-19 Compounds
PCT/EP2016/078360 WO2017085329A1 (en) 2015-11-19 2016-11-21 Azithromycin derivatives with epithelial barrier enhancement properties

Publications (1)

Publication Number Publication Date
CY1123418T1 true CY1123418T1 (el) 2021-12-31

Family

ID=55133040

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20201100750T CY1123418T1 (el) 2015-11-19 2020-08-12 Παραγωγα αζιθρομυκινης με ιδιοτητες ενισχυσης επιθηλιακου φραγμου

Country Status (19)

Country Link
US (3) US10723752B2 (https=)
EP (2) EP3377511B1 (https=)
JP (2) JP6849896B2 (https=)
KR (2) KR20240157138A (https=)
CN (2) CN108290919B (https=)
CA (1) CA3005088A1 (https=)
CY (1) CY1123418T1 (https=)
DK (1) DK3377511T3 (https=)
ES (1) ES2810703T3 (https=)
GB (1) GB201520419D0 (https=)
HR (1) HRP20201246T1 (https=)
HU (1) HUE050307T2 (https=)
LT (1) LT3377511T (https=)
PL (1) PL3377511T3 (https=)
PT (1) PT3377511T (https=)
RS (1) RS60698B1 (https=)
SI (1) SI3377511T1 (https=)
SM (1) SMT202000426T1 (https=)
WO (1) WO2017085329A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201520419D0 (en) 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds
KR20220156570A (ko) 2020-03-12 2022-11-25 조에티스 서비시즈 엘엘씨 면역조절성 유레아 아잘라이드
AU2022343476B2 (en) * 2021-09-07 2025-02-20 Zoetis Services Llc Immunomodulating azalides
CN121038797A (zh) 2023-03-22 2025-11-28 艾比恩多制药有限责任公司 用于治疗嗜酸性粒细胞相关疾病的阿奇霉素衍生物
GB202404587D0 (en) 2024-03-28 2024-05-15 Epiendo Pharmaceuticals Ehf Chemical forms
GB202412461D0 (en) 2024-08-23 2024-10-09 Epiendo Pharmaceuticals Ehf Medial use

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
HRP20010018A2 (en) * 2001-01-09 2002-12-31 Pliva D D Novel anti-inflammatory compounds
AU2003219770B2 (en) * 2002-02-15 2008-10-09 Merckle Gmbh Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
RU2330858C2 (ru) 2002-07-08 2008-08-10 Глаксомитклайн Истраживацки Центар Загреб Д.О.О. Новые соединения, составы и способы лечения воспалительных заболеваний и состояний
ITMI20022292A1 (it) 2002-10-29 2004-04-30 Zambon Spa 9a-azalidi ad attivita' antiinfiammatoria.
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7767797B1 (en) * 2004-09-30 2010-08-03 Synovo Gmbh Macrocyclic compounds and methods of use thereof
PT1851236E (pt) 2005-01-13 2010-10-25 Glaxosmithkline Zagreb Macrólidos com actividade anti-inflamatória
EP1841776B1 (en) * 2005-01-13 2008-12-31 GlaxoSmithKline istrazivacki centar Zagreb d.o.o. Decladinosyl-macrolides with anti-inflammatory activity
CN1837225A (zh) 2005-08-23 2006-09-27 济南思创生物技术有限公司 阿奇霉素衍生物及其制法和药物应用
RU2455308C2 (ru) 2006-05-01 2012-07-10 Тайсо Фармасьютикал Ко., Лтд. Макролидные производные
CN101074251B (zh) * 2007-06-22 2011-06-15 山东大学 阿奇霉素4"-氨甲酸酯衍生物、制备方法及其药物组合物
WO2009006403A2 (en) * 2007-06-29 2009-01-08 Georgia Tech Research Corporation Non-peptide macrocyclic histone deacetylase (hdac) inhibitors and methods of making and using thereof
WO2010086351A1 (en) * 2009-01-30 2010-08-05 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 3'-n-substituted 9-deoxo-9a-methyl-9a-aza-homoerythromycin having antimalarial activity
CA2814333A1 (en) * 2010-10-10 2012-04-19 Synovo Gmbh Anti-inflammatory macrolides
GB201105633D0 (en) * 2011-04-01 2011-05-18 Norbrook Lab Ltd Antibotic compounds
EP2831083A4 (en) * 2012-03-27 2016-03-09 Michael W Burnet INFLAMMATORY MAKROLIDE
AU2014252462A1 (en) 2013-04-10 2015-10-01 Probiotic Pharmaceuticals Aps Azithromycin antimicrobial derivatives with non-antibiotic pharmaceutical effect
GB201520419D0 (en) 2015-11-19 2016-01-06 Epi Endo Pharmaceuticals Ehf Compounds

Also Published As

Publication number Publication date
HRP20201246T1 (hr) 2020-11-13
US20220106349A1 (en) 2022-04-07
WO2017085329A1 (en) 2017-05-26
HUE050307T2 (hu) 2020-11-30
CN108290919B (zh) 2022-06-17
SI3377511T1 (sl) 2020-10-30
US20200317710A1 (en) 2020-10-08
CN108290919A (zh) 2018-07-17
KR20240157138A (ko) 2024-10-31
PL3377511T3 (pl) 2020-11-16
US12049477B2 (en) 2024-07-30
CN114933620B (zh) 2026-03-31
EP3708573A1 (en) 2020-09-16
JP2018534324A (ja) 2018-11-22
US20180354981A1 (en) 2018-12-13
LT3377511T (lt) 2020-09-25
US10723752B2 (en) 2020-07-28
JP6849896B2 (ja) 2021-03-31
EP3377511A1 (en) 2018-09-26
RS60698B1 (sr) 2020-09-30
JP2021073303A (ja) 2021-05-13
KR102724114B1 (ko) 2024-10-29
HK1255270A1 (en) 2019-08-09
JP7256558B2 (ja) 2023-04-12
US11236120B2 (en) 2022-02-01
DK3377511T3 (da) 2020-08-17
ES2810703T3 (es) 2021-03-09
CA3005088A1 (en) 2017-05-26
PT3377511T (pt) 2020-08-21
EP3377511B1 (en) 2020-05-13
GB201520419D0 (en) 2016-01-06
CN114933620A (zh) 2022-08-23
KR20180077282A (ko) 2018-07-06
SMT202000426T1 (it) 2020-09-10

Similar Documents

Publication Publication Date Title
CY1123418T1 (el) Παραγωγα αζιθρομυκινης με ιδιοτητες ενισχυσης επιθηλιακου φραγμου
CY1124407T1 (el) Ενωσεις αναστολεα αυτοταξινης
CY1124959T1 (el) Αναστολεις λυσινης ειδικης απομεθυλασης-1
JOP20200192A1 (ar) أجسام مضادة لـ tigit
CY1122966T1 (el) 5-βρωμο-2,6-δι-(1η-πυραζολ-1-υλ)πυριμιδιν-4-αμινη για χρηση στη θεραπευτικη αγωγη καρκινου
CY1120969T1 (el) Παραγωγα κινοξαλινης χρησιμα ως τροποποιητες fgfr κινασης
CY1120862T1 (el) Παραγοντες επαγωγης αποπτωσης για τη θεραπευτικη αγωγη καρκινου και ανοσων και αυτοανοσων ασθενειων
CY1120582T1 (el) Φαρμακευτικες συνθεσεις για την αγωγη παθησεων μεσολαβουμενων απο ρυθμιστη διαμεμβρανικης αγωγιμοτητας κυστικης ινωσης
CY1120452T1 (el) Παραγωγο αμιδιου πυραζολης
CY1123811T1 (el) Κρυσταλλικη μορφη αναστολεα pde4
CY1124243T1 (el) Αναστολη του ιοντικου διαυλου υποδοχεα παροδικου δυναμικου α1
CY1116424T1 (el) Παραγωγο αδενινης ως αναστολεας ρι3κ
CY1123216T1 (el) Αναστολεις της gls1 για την αντιμετωπιση νοσων
MX377845B (es) Inhibidores de calicreína plasmática humana.
CY1121273T1 (el) Παραγωγα 6-αλκυνυλο-πυριδινης ως smac μιμητικα
EA201991196A1 (ru) Претерпевшие самосборку диблок-сополимеры, состоящие из pegmema и несущих лекарственное средство полимерных сегментов
CY1118399T1 (el) Ενωσεις βενζοφουρανιου για την θεραπεια μολυνσεων ιου ηπατιτιδας c
MX386702B (es) Tratamiento con halogeno de ataque cardiaco y lesion isquemica.
MX382919B (es) Nuevos compuestos.
LT3890767T (lt) Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui
MX2019001634A (es) Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos.
MX2018006953A (es) Compuestos de platino funcionalizados con monomaleimida para la terapia del cancer.
AU2016380190A8 (en) Deuterated compounds for treating cancer and related diseases and conditions, and compositions and methods thereof
CY1118641T1 (el) Δικυκλικες ενωσεις
EA201892475A1 (ru) Оксабороловые сложные эфиры, их применение